latest news releases from the newsroom
The FDA rejects application for the registration og The NGAL TestTM
The Food and Drug Administration (FDA) has informed BioPorto A/S (BioPorto)
that the registration application for The NGAL Test™ has been rejected on the
grounds that the submission does not provide adequate clinical and analytical
data to support a reasonable assurance of approval of the device.
FDA's response means that BioPorto cannot begin commercialization of The NGAL
Test™ for clinical use in the US as previously expected, whereas sales for
research use continues.
Peter M. Eriksen, C
United States Postal Service
US Postal Service Dedicates World Stamp Show
NEW YORK, May 28, 2016 (GLOBE NEWSWIRE) -- The U.S. Postal Service dedicated a Forever Stamp Folio celebrating World Stamp Show-NY 2016, which opened today at the Jacob Javits Convention Center in New York City and continues through June 4. The United States plays host to the sanctioned international stamp show only once every 10 years, the first since being held in Washington in 2006.